v3.26.1
Collaboration, License, and Other Agreements - Schedule of Contract Balances, Antibody Collaboration (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Disaggregation of Revenue [Line Items]    
Accounts receivable, net $ 5,731.0 $ 5,741.1
Sanofi Collaboration Agreement, Antibody    
Disaggregation of Revenue [Line Items]    
Accounts receivable, net 1,713.2 1,610.6
Deferred revenue $ 545.4 $ 442.3